Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 10:45 (1840 d 10:34 ago) – Posting: # 20125
Views: 3,771

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


Edit: Category changed; see also this post #1. Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,669 registered users;
65 visitors (0 registered, 65 guests [including 5 identified bots]).
Forum time: 21:19 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5